Skip Header

1 - 25 of 172 results for author:"Seidman J.G." in Literature citations

Page of 7 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (65)

Truncations of titin causing dilated cardiomyopathy.

Herman D.S., Lam L., Taylor M.R., Wang L., Teekakirikul P., Christodoulou D., Conner L., DePalma S.R., McDonough B., Sparks E. et al.

N. Engl. J. Med. 366:619-628(2012) · Mapped (13)

Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis.

Delgado-Olguin P., Huang Y., Li X., Christodoulou D., Seidman C.E., Seidman J.G., Tarakhovsky A., Bruneau B.G.

Nat. Genet. 44:343-347(2012) · Mapped (114)

Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury.

Yoshioka J., Chutkow W.A., Lee S., Kim J.B., Yan J., Tian R., Lindsey M.L., Feener E.P., Seidman C.E., Seidman J.G. et al.

J. Clin. Invest. 122:267-279(2012) · Mapped (2)

Polycomb repressive complex 2 regulates normal development of the mouse heart.

He A., Ma Q., Cao J., von Gise A., Zhou P., Xie H., Zhang B., Hsing M., Christodoulou D.C., Cahan P. et al.

Circ. Res. 110:406-415(2012) · Mapped (6)

Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.

Holleboom A.G., Karlsson H., Lin R.S., Beres T.M., Sierts J.A., Herman D.S., Stroes E.S., Aerts J.M., Kastelein J.J., Motazacker M.M. et al.

Cell Metab. 14:811-818(2011) · Mapped (5)

CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis.

Neckar J., Silhavy J., Zidek V., Landa V., Mlejnek P., Simakova M., Seidman J.G., Seidman C., Kazdova L., Klevstig M. et al.

Physiol. Genomics 44:173-182(2012) · Mapped (2)

Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.

Lemaire S.A., McDonald M.L., Guo D.C., Russell L., Miller C.C., Johnson R.J., Bekheirnia M.R., Franco L.M., Nguyen M., Pyeritz R.E. et al.

Nat. Genet. 43:996-1000(2011) · Mapped (6)

Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome.

Bowen M.E., Boyden E.D., Holm I.A., Campos-Xavier B., Bonafe L., Superti-Furga A., Ikegawa S., Cormier-Daire V., Bovee J.V., Pansuriya T.C. et al.

PLoS Genet. 7:e1002050-e1002050(2011) · Mapped (6)

Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development.

Moskowitz I.P., Wang J., Peterson M.A., Pu W.T., Mackinnon A.C., Oxburgh L., Chu G.C., Sarkar M., Berul C., Smoot L. et al.

Proc. Natl. Acad. Sci. U.S.A. 108:4006-4011(2011) · Mapped (27)

Age-related autocrine diabetogenic effects of transgenic resistin in spontaneously hypertensive rats: gene expression profile analysis.

Pravenec M., Zidek V., Landa V., Simakova M., Mlejnek P., Silhavy J., Maxova M., Kazdova L., Seidman J.G., Seidman C.E. et al.

Physiol. Genomics 43:372-379(2011) · Mapped (3)

Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation.

Chen P.C., Wakimoto H., Conner D., Araki T., Yuan T., Roberts A., Seidman C., Bronson R., Neel B., Seidman J.G. et al.

J. Clin. Invest. 120:4353-4365(2010) · Mapped (89)

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Konno T., Chen D., Wang L., Wakimoto H., Teekakirikul P., Nayor M., Kawana M., Eminaga S., Gorham J.M., Pandya K. et al.

Proc. Natl. Acad. Sci. U.S.A. 107:18097-18102(2010) · Mapped (20)

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta.

Teekakirikul P., Eminaga S., Toka O., Alcalai R., Wang L., Wakimoto H., Nayor M., Konno T., Gorham J.M., Wolf C.M. et al.

J. Clin. Invest. 120:3520-3529(2010) · Mapped (15)

Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.

Alcalai R., Wakimoto H., Arad M., Planer D., Konno T., Wang L., Seidman J.G., Seidman C.E., Berul C.I.

J. Cardiovasc. Electrophysiol. 22:316-324(2011) · Mapped (2)

Genome-wide identification of mouse congenital heart disease loci.

Kamp A., Peterson M.A., Svenson K.L., Bjork B.C., Hentges K.E., Rajapaksha T.W., Moran J., Justice M.J., Seidman J.G., Seidman C.E. et al.

Hum. Mol. Genet. 19:3105-3113(2010) · Mapped (1)

A novel custom resequencing array for dilated cardiomyopathy.

Zimmerman R.S., Cox S., Lakdawala N.K., Cirino A., Mancini-DiNardo D., Clark E., Leon A., Duffy E., White E., Baxter S. et al.

Genet. Med. 12:268-278(2010) · Mapped (96)

Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy.

Saltzman A.J., Mancini-DiNardo D., Li C., Chung W.K., Ho C.Y., Hurst S., Wynn J., Care M., Hamilton R.M., Seidman G.W. et al.

Circ. Res. 106:1549-1552(2010) · Mapped (8)

Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2.

Liu X., Han D., Li J., Han B., Ouyang X., Cheng J., Li X., Jin Z., Wang Y., Bitner-Glindzicz M. et al.

Am. J. Hum. Genet. 86:65-71(2010) · UniProtKB (2) · Mapped (9)

Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods.

Zvaritch E., Kraeva N., Bombardier E., McCloy R.A., Depreux F., Holmyard D., Kraev A., Seidman C.E., Seidman J.G., Tupling A.R. et al.

Proc. Natl. Acad. Sci. U.S.A. 106:21813-21818(2009) · Mapped (2)

Cardiac myosin binding protein-C is essential for thick-filament stability and flexural rigidity.

Nyland L.R., Palmer B.M., Chen Z., Maughan D.W., Seidman C.E., Seidman J.G., Kreplak L., Vigoreaux J.O.

Biophys. J. 96:3273-3280(2009) · Mapped (6)

Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.

Fox A.A., Collard C.D., Shernan S.K., Seidman C.E., Seidman J.G., Liu K.Y., Muehlschlegel J.D., Perry T.E., Aranki S.F., Lange C. et al.

Anesthesiology 110:738-747(2009) · Mapped (15)

Sequencing of TGF-beta pathway genes in familial cases of intracranial aneurysm.

Santiago-Sim T., Mathew-Joseph S., Pannu H., Milewicz D.M., Seidman C.E., Seidman J.G., Kim D.H.

Stroke 40:1604-1611(2009) · Mapped (33)

Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.

Schmitt J.P., Ahmad F., Lorenz K., Hein L., Schulz S., Asahi M., Maclennan D.H., Seidman C.E., Seidman J.G., Lohse M.J.

Circulation 119:436-444(2009) · Mapped (3)

E2F3 plays an essential role in cardiac development and function.

King J.C., Moskowitz I.P., Burgon P.G., Ahmad F., Stone J.R., Seidman J.G., Lees J.A.

Cell Cycle 7:3775-3780(2008) · Mapped (7)

Eya4 regulation of Na+/K+-ATPase is required for sensory system development in zebrafish.

Wang L., Sewell W.F., Kim S.D., Shin J.T., MacRae C.A., Zon L.I., Seidman J.G., Seidman C.E.

Development 135:3425-3434(2008) · Mapped (21)

to top of page·

Page of 7 | Next »